The Advisory Committee on Borderline Substances have found insufficient evidence that the widespread use of Nicorette would produce telling benefits to patients using it, and have therefore decided that Nicorette should not at present be regarded as a drug for prescription in the NHS. The ACBS will review this decision when important new evidence becomes available.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.